Journal
FRONTIERS IN PHARMACOLOGY
Volume 7, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2016.00078
Keywords
radiotherapy; tumor microenvironment; angiogenesis; hypoxia; inflammation; cancer-associated fibroblasts; treatment combination
Categories
Funding
- Fonds National pour la Recherche Scientifique (FNRS) [7.4527.10]
- Fonds pour la Recherche Scientifique et Medicale (FRSM) [1691836]
- Centre Anti-Cancereux (CAC, University of Liege, Belgium)
- Fonds :Leon Fredericq (University of Liege, Belgium)
Ask authors/readers for more resources
Radiotherapy (RT) is one of the most important modalities for cancer treatment. For many years, the impact of RT on cancer cells has been extensively studied. Recently, the tumor microenvironment (TME) emerged as one of the key factors in therapy resistance. RT is known to influence and modify diverse components of the TME. Hence, we intent to review data from the literature on the impact of low and high single dose, as well as fractionated RT on host cells (endothelial cells, fibroblasts, immune and inflammatory cells) and the extracellular matrix. Optimizing the schedule of RT (i.e., dose per fraction) and other treatment modalities is a current challenge. A better understanding of the cascade of events and TME remodeling following RT would be helpful to design optimal treatment combination.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available